Catalyst Wire Dossier Catalyst Wire Dossier

mFOLFOX6+Bevacizumab

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mFOLFOX6+Bevacizumab, covering 2021-09-27 to 2021-09-27. Get the full timeline:

Most recent: Clinical Trial Update: mFOLFOXIRI+Bev vs. mFOLFOX6+Bev for RAS Mutant Unresectable Colorectal Liver-limited Metastases [Phase 3]

See pricing